United States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks
Outcome
OIG enforcement action against United States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks for false claims, kickbacks.
Details
United States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks — OIG Enforcement (2010)
OIG took enforcement action against United States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks in PA in 2010 involving false claims, kickbacks violations in the Independent Pharmacies sector.
Violation types: False Claims, Kickbacks
Entity type: Pharmacy
Penalty type: Settlement
Location: PA
Source: United States Intervenes In False Claims Act Lawsuit Against Drug Maker Mallinckrodt Alleging Illegal Kickbacks
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works